Ivan Feldi
Ivan Feldi has a total of 14 co-authors. Here are the top co-authors by number of shared publications:
- Tatjana Bačun
Faculty of Medicine, Josip Juraj Strossmayer University of Osijek, Josipa Huttlera 4, 31000 Osijek, Croatia
3 shared publications - Dunja Šojat
Josip Juraj Strossmayer University of Osijek
2 shared publications - Mario Šafer
Department of Internal Medicine, General Hospital Virovitica, 33000 Virovitica, Croatia
2 shared publications - Marko Pirić
Department of Family Medicine, Faculty of Medicine, Josip Juraj Strossmayer University of Osijek, 31000 Osijek, Croatia
2 shared publications - Aleksandar Kibel
Department of Clinical Medicine, Faculty of Dental Medicine and Health Osijek, Josip Juraj Strossmayer University of Osijek, 31000 Osijek, Croatia
1 shared publication - Barbara Grubišić
Clinic for Infectious Diseases, University Hospital Centre Osijek, 4 Josip Huttler Street, HR-31000 Osijek, Croatia
1 shared publication
Latest Publications
- Open Access
- 27 August 2026
- Published by MDPI AG in Biomedicines
- Vol. 14 (9) , 1921
The Influence of Statin Therapy on Markers of Endothelial Dysfunction, Endocan and Endoglin, in Postmenopausal Women—A Prospective Study
Background: Postmenopausal women experience an increased risk of cardiovascular diseases due to estrogen deficiency, which induces endothelial dysfunction. Statins primarily lower cardiovascular risk by altering lipid profiles, but they also exert non-lipid-modifying, pleiotropic effects on the vascular endothelium. This prospective observational study was aimed to evaluate and compare the impact of atorvastatin and rosuvastatin on plasma markers of endothelial dysfunction, endocan and endoglin, in postmenopausal women undergoing primary cardiovascular prevention. Methods: A total of 128 postmenopausal Croatian women (aged 45–70 years) with dyslipidemia were prospectively enrolled and assigned to two treatment groups receiving either atorvastatin or rosuvastatin therapy based on primary care clinical management. Cardiovascular risk was evaluated using the SCORE2 algorithm, and statin doses were titrated up to 16 weeks until target LDL-C values were achieved. Plasma concentrations of endocan and endoglin, alongside lipid profiles, were quantified via ELISA and laboratory analyses before and after the treatment period. Results: Atorvastatin and rosuvastatin therapies significantly decreased plasma concentrations of both endocan and endoglin (p < 0.001 for both groups). No statistically significant differences in the absolute changes in these biomarkers were observed between therapy groups. The reduction in endocan and endoglin levels occurred independently of whether the participants achieved their clinical target LDL-C values. While statin-induced reduction in endoglin was directly driven by the extent of LDL-C lowering, the decrease in endocan occurred independently of lipid changes, with both biomarker reductions being greatest in women with higher baseline levels regardless of statin type or dose. ROC curve analysis demonstrated that neither biomarker had significant clinical discriminatory ability to predict the attainment of target LDL-C levels. Conclusions: Atorvastatin and rosuvastatin treatment was associated with significant reductions in plasma endocan and endoglin concentrations in postmenopausal women receiving primary cardiovascular prevention.
- 27 August 2026
- Published by MDPI AG in Biomedicines
- Vol. 14 (9) , 1921
Open AccessThe Influence of Statin Therapy on Markers of Endothelial Dysfunction, Endocan and Endoglin, in Postmenopausal Women—A Prospective Study
Background: Postmenopausal women experience an increased risk of cardiovascular diseases due to estrogen deficiency, which induces endothelial dysfunction. Statins primarily lower cardiovascular risk by altering lipid profiles, but they also exert non-lipid-modifying, pleiotropic effects on the vascular endothelium. This prospective observational study was aimed to evaluate and compare the impact of atorvastatin and rosuvastatin on plasma markers of endothelial dysfunction, endocan and endoglin, in postmenopausal women undergoing primary cardiovascular prevention. Methods: A total of 128 postmenopausal Croatian women (aged 45–70 years) with dyslipidemia were prospectively enrolled and assigned to two treatment groups receiving either atorvastatin or rosuvastatin therapy based on primary care clinical management. Cardiovascular risk was evaluated using the SCORE2 algorithm, and statin doses were titrated up to 16 weeks until target LDL-C values were achieved. Plasma concentrations of endocan and endoglin, alongside lipid profiles, were quantified via ELISA and laboratory analyses before and after the treatment period. Results: Atorvastatin and rosuvastatin therapies significantly decreased plasma concentrations of both endocan and endoglin (p < 0.001 for both groups). No statistically significant differences in the absolute changes in these biomarkers were observed between therapy groups. The reduction in endocan and endoglin levels occurred independently of whether the participants achieved their clinical target LDL-C values. While statin-induced reduction in endoglin was directly driven by the extent of LDL-C lowering, the decrease in endocan occurred independently of lipid changes, with both biomarker reductions being greatest in women with higher baseline levels regardless of statin type or dose. ROC curve analysis demonstrated that neither biomarker had significant clinical discriminatory ability to predict the attainment of target LDL-C levels. Conclusions: Atorvastatin and rosuvastatin treatment was associated with significant reductions in plasma endocan and endoglin concentrations in postmenopausal women receiving primary cardiovascular prevention.
- Open Access
- 26 February 2026
- Published by MDPI AG in Biomedicines
- Vol. 14 (3) , 518
Association Between Statin Use, Cytokine Storm, and Clinical Outcomes in COVID-19 Patients with Diabetes
Objective: To examine patterns of inflammatory markers, kidney function, and clinical outcomes in patients with type 2 diabetes (T2D) hospitalized for COVID-19, with particular focus on the impact of therapy with hydroxymethylglutaryl-CoA reductase inhibitors (statins). Methods: We conducted a retrospective analysis of 440 T2D patients, divided into those who were on statin therapy prior to hospitalization and those who were not. Clinical characteristics, laboratory markers of inflammation, kidney function, and the requirement for invasive ventilation were compared between the groups. Results: Patients were predominantly older adults with a high burden of comorbidities, most commonly arterial hypertension and chronic kidney disease, and presented with elevated inflammatory markers and hyperglycemia at admission. Statin users more frequently had cardiovascular comorbidities and showed lower unadjusted interleukin-6 (IL-6) and ferritin levels, although these differences were not significant after multivariable adjustment. Importantly, statin therapy was independently associated with lower odds of mechanical ventilation in multivariable analysis. Conclusions: Despite a higher prevalence of cardiovascular comorbidities, diabetic patients receiving statins had lower odds of mechanical ventilation. No independent association with inflammatory markers was confirmed, and the observed relationship with respiratory outcomes should be interpreted cautiously given the observational design.
- 26 February 2026
- Published by MDPI AG in Biomedicines
- Vol. 14 (3) , 518
Open AccessAssociation Between Statin Use, Cytokine Storm, and Clinical Outcomes in COVID-19 Patients with Diabetes
Objective: To examine patterns of inflammatory markers, kidney function, and clinical outcomes in patients with type 2 diabetes (T2D) hospitalized for COVID-19, with particular focus on the impact of therapy with hydroxymethylglutaryl-CoA reductase inhibitors (statins). Methods: We conducted a retrospective analysis of 440 T2D patients, divided into those who were on statin therapy prior to hospitalization and those who were not. Clinical characteristics, laboratory markers of inflammation, kidney function, and the requirement for invasive ventilation were compared between the groups. Results: Patients were predominantly older adults with a high burden of comorbidities, most commonly arterial hypertension and chronic kidney disease, and presented with elevated inflammatory markers and hyperglycemia at admission. Statin users more frequently had cardiovascular comorbidities and showed lower unadjusted interleukin-6 (IL-6) and ferritin levels, although these differences were not significant after multivariable adjustment. Importantly, statin therapy was independently associated with lower odds of mechanical ventilation in multivariable analysis. Conclusions: Despite a higher prevalence of cardiovascular comorbidities, diabetic patients receiving statins had lower odds of mechanical ventilation. No independent association with inflammatory markers was confirmed, and the observed relationship with respiratory outcomes should be interpreted cautiously given the observational design.
- Open Access
- 12 November 2020
- Published by Faculty of Medicine Osijek in Southeastern European medical journal
- Vol. 4 (2) , 108-112
Pathohistological Diagnosis of Adrenal Tumors: Experience of a Single Center
Introduction: To investigate adrenal tumors of patients operated on at the University Hospital Center Osijek from 2016 to 2019 for the purpose of examining the location and histopathological findings of the tumors and determining whether there is a difference related to that in terms of the age and sex of the subjects.Subjects and Methods: This was a cross-sectional study with historical data analysis. The subjects were patients of both sexes (N=23) diagnosed with adrenal tumors (N=23) who underwent surgery at the University Hospital Center Osijek in the period from 2016 to 2019. The archive was used in the University Hospital Center Osijek.Results: Adrenal tumors were more often unilateral than bilateral. No differences were found in the localization of tumors of the right and left adrenal glands. Benign tumors were more common than malignant tumors and were the most common adenoma. Seventeen women underwent surgery and were 10 years older on average (61.6 years). There were no significant differences regarding tumor occurrence with respect to the patients’ age. Benign tumors were more common in women, but the difference was not statistically significant. Regarding histopathological findings, women were more likely to have adenoma (N=10) and hyperplasia (N=4), while men had other benign tumors (N=3) and metastatic tumors (N=1). However, the difference was not statistically significant.Conclusion: In patients who have undergone surgery for adrenal tumors, there were more unilateral tumors compared to bilateral ones, but there was no difference in tumor localization (left and right). Benign tumors were more common, the most common of which were adenomas. There were no significant differences with respect to age and sex.
- 12 November 2020
- Published by Faculty of Medicine Osijek in Southeastern European medical journal
- Vol. 4 (2) , 108-112
Open AccessPathohistological Diagnosis of Adrenal Tumors: Experience of a Single Center
Introduction: To investigate adrenal tumors of patients operated on at the University Hospital Center Osijek from 2016 to 2019 for the purpose of examining the location and histopathological findings of the tumors and determining whether there is a difference related to that in terms of the age and sex of the subjects.Subjects and Methods: This was a cross-sectional study with historical data analysis. The subjects were patients of both sexes (N=23) diagnosed with adrenal tumors (N=23) who underwent surgery at the University Hospital Center Osijek in the period from 2016 to 2019. The archive was used in the University Hospital Center Osijek.Results: Adrenal tumors were more often unilateral than bilateral. No differences were found in the localization of tumors of the right and left adrenal glands. Benign tumors were more common than malignant tumors and were the most common adenoma. Seventeen women underwent surgery and were 10 years older on average (61.6 years). There were no significant differences regarding tumor occurrence with respect to the patients’ age. Benign tumors were more common in women, but the difference was not statistically significant. Regarding histopathological findings, women were more likely to have adenoma (N=10) and hyperplasia (N=4), while men had other benign tumors (N=3) and metastatic tumors (N=1). However, the difference was not statistically significant.Conclusion: In patients who have undergone surgery for adrenal tumors, there were more unilateral tumors compared to bilateral ones, but there was no difference in tumor localization (left and right). Benign tumors were more common, the most common of which were adenomas. There were no significant differences with respect to age and sex.